Problems of interchangeability of systemic interferons for treatment of multiple sclerosis
Problems of interchangeability of systemic interferons for treatment of multiple sclerosis are described. An analysis of 1,643 spontaneous reports existing in the Russian database for the period 2009 to 2015 was made in order to identify information on adverse reactions that occurred after replaceme...
Main Authors: | I. I. Snegireva, E. Yu. Pasternak, K. E. Zatolochina, M. A. Darmostukova, R. N. Alyautdin, V. A. Polivanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/86 |
Similar Items
-
Modern approaches to collecting and reporting information on side effects
by: K. E. Zatolochina, et al.
Published: (2018-02-01) -
Medication errors associated with carbapenems
by: A. V. Kuz’mina, et al.
Published: (2018-05-01) -
Social media as a source of information on drug safety and how to extract it
by: I. I. Snegireva, et al.
Published: (2018-02-01) -
ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT
by: A. A. Toporov, et al.
Published: (2018-02-01) -
The Russian study of «off-label» drug use in pediatric practice: 2015 vs 2012
by: A. R. Titova, et al.
Published: (2018-05-01)